Maja Artandi, MD

Internal medicine doctor

Clinical Assistant Professor, Medicine - General Medical Disciplines
4.9 out of 5
264 Patient Ratings
8 Patient Comments

Internal Medicine at Hoover Pavilion

  • 211 Quarry Road
  • Palo Alto, CA 94304
  • Phone: 650-498-9000
Learn More About the Clinic » Getting Here » Make An Appointment

Professional Education

Residency: Stanford University Medical Center (2004) CA

Board Certification: Internal Medicine, American Board of Internal Medicine (2004)

Internship: Stanford University Medical Center (2002) CA

Residency: Medizinische Hochschule Hannover (1999) Germany

Medical Education: Georg-August University Faculty Medicine (1997) Germany

Residency, Stanford Medical School, Internship and Residency (2004)

Fellow, Stanford University, Postdoctoral Fellow (2001)

Fellow, Dana-Farber Cancer Institute, Postdoctoral Fellow (2000)

Postgrad, Medical University of Hannover, Internal Medicine (1999)

M.D., Georg August University, Doctoral Thesis (1997)

M.D., Georg August University, Medical School (1997)

Honors & Awards

DGIM research award, Stanford Department of General Internal Medicine (2010)

Exceptional Preceptor in the Ambulatory Medicine Clerkship, Stanford University (2006)

Erasmus scholarship to study medicine in a foreign country, ERASMUS Programme (1997)

Administrative Appointments

Clinical Assistant Professor, Stanford Medical School (2009 - Present)

Clinical Instructor, Stanford Medical School (2006 - 2009)

Clinical Instructor, Stanford Medical School (2005 - 2005)

Medical Staff, Palo Alto Veteran Affairs Hospital (2004 - 2008)

Patient Ratings and Comments

4.9

Friendliness

4.8

Recommended to others

4.8

Explanations

4.8

Listens

4.8

Includes you in decisions

4.9

Clear Communication

4.9

Confidence in your doctor

4.5

Wait times

SHC Patient, Nov 2014

Dr. Artandi is my new PCP. I had an excellent first visit with her.

SHC Patient, Sep 2014

I have a lot of respect for Dr. Maja Artandi - she listens, is professional, treats you like a person - Excellent!

SHC Patient, Aug 2014

Excellent provider overall.

SHC Patient, Aug 2014

My experience is only good.

View all 8 patient comments

TERT promotes epidermal proliferation through transcriptional control of a Myc- and Wnt-related developmental program.
Choi, J. S., Sarin, K., Venteicher, A.S., & S. (2008). TERT promotes epidermal proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet.

Conditional telomerase induction causes proliferation of hair follicle stem cells
Sarin, K. Y., Cheung, P., Gilison, D., Lee, E., Tennen, R. I., & Artandi, S. E. (2005). Conditional telomerase induction causes proliferation of hair follicle stem cells. NATURE, 436(7053), 1048-1052.

Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo clinic regimen in the first line therapy of advance colorectal cancer
Graeven U., Ridwelski K., Artandi M., Espana P., & Scholmerich J et al. (2005). Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo clinic regimen in the first line therapy of advance colorectal cancer. Oncol Rep.

Constitutive telomerase expression promotes mammary carcinomas in aging mice
Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., & DePinho, R. A. (2002). Constitutive telomerase expression promotes mammary carcinomas in aging mice. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(12), 8191-8196.

Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas
Kubicka, S., Rudolph, K. L., Tietze, M. K., Lorenz, M., & Manns, M. (2001). Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. HEPATO-GASTROENTEROLOGY, 48(39), 783-789.

Murine models of malignant melanoma
Tietze, M. K., & Chin, L. (2000). Murine models of malignant melanoma. MOLECULAR MEDICINE TODAY, 6(10), 408-410.

I kappa B alpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas
Tietze, M. K., Wuestefeld, T., Paul, Y., Zender, L., Trautwein, C., & Kubicka, S. (2000). I kappa B alpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas. CANCER GENE THERAPY, 7(10), 1315-1323.

Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area
Kubicka S., Rudolph KL., Hanke T., Tietzke MK., Tillmann H.., & Manns M. (2000). Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area. Liver.

NfkB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis
Kuehnel F., Zender L., Paul Y., Tietzke MK., Trautwein C., & Kubicka S. (2000). NfkB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem.

4.9 out of 5
264 Patient Ratings
8 Patient Comments

SHC Patient, Nov 2014

Dr. Artandi is my new PCP. I had an excellent first visit with her.

SHC Patient, Sep 2014

I have a lot of respect for Dr. Maja Artandi - she listens, is professional, treats you like a person - Excellent!

SHC Patient, Aug 2014

Excellent provider overall.

SHC Patient, Aug 2014

My experience is only good.

SHC Patient, Jun 2014

Dr. Artandi always has time for me.

SHC Patient, Jan 2014

Dr. Artandi is one of the very best doctor I have ever seen one is caring, professional, understanding. She is the very best of the best.

SHC Patient, Jan 2014

Excellent doctor!

SHC Patient, Dec 2013

Dr. Artandi is not my regular doc but I thought she was great. I would ask for her if my reg. doc not available.